National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 7394-7395 [2019-03751]
Download as PDF
<![CDATA[
7394
Federal Register / Vol. 84, No. 42 / Monday, March 4, 2019 / Notices
continue to guide and support public
health capacities to prepare for, detect,
and respond to potential public health
emergencies caused by human influenza
viruses, zoonotic diseases, and other
emerging infectious diseases with
pandemic potential in West and Central
Africa, and Southeast Asia to support
the health security of the United States.
The total proposed cost of the Single
Source Cooperative Agreement is not to
exceed $5 million over the five-year life
of the Cooperative Agreement.
DATES:
Project Period: The period of
performance is from September 30, 2019
to September 30, 2024.
Award Amount: Estimate $5 million.
FOR FURTHER INFORMATION CONTACT:
Maria Marinissen—Maria
.Marinissen@hhs.gov, (202) 205–4214.
Robin Moudy—Robin.Moudy@
hhs.gov, 202–260–2105.
SUPPLEMENTARY INFORMATION: The Office
of the Assistant Secretary for
Preparedness and Response (ASPR),
International Policy Branch is the
program office for this Cooperative
Agreement:
Single Source Justification: Founded
in 1887, Institut Pasteur, based in Paris,
has an international research network
with 33 institutes globally committed to
advancing science, medicine and public
health, with especially unmatched reach
in the Francophone world. This
partnership between ASPR and IPIN
gives ASPR access to information and
the ability to build international partner
capacity to prepare for, detect, and
respond to potential public health
emergencies caused by human influenza
viruses, zoonotic diseases, and other
emerging infectious diseases with
pandemic potential in West and Central
Africa, and Southeast Asia that could
have an severe impact on the health
security of the United States and its
citizens.
The focus will be on countries in
West and Central Africa, Madagascar,
and Southeast Asia (Cambodia) where
IPIN is the primary laboratory partner of
the host government, although
supported partnerships may extend
beyond those countries and regions.
Prior to each annual award, affiliated
laboratories will submit their proposed
scope of work, which may be adjusted
over the course of the year based on
changing needs and priorities or other
exigent circumstances, such as a critical
outbreak response.
The five-year scope of work of the
renewed cooperative agreement will
build upon the successes of past
activities, including the following
overarching objectives:
VerDate Sep<11>2014
17:33 Mar 01, 2019
Jkt 247001
• Facilitate public health emergency
planning, rapid epidemiologic
responses, public health event
assessment pursuit to the IHR,
international data or event reporting as
determined by the host government, and
assist with emergency management
where needed;
• Ensure One Health coordination
with the WHO, the World Organization
for Animal Health (OIE), national
human, animal, and environmental
health agencies, and others as needed to
address zoonotic disease threats.
• System in place for medical
countermeasures distribution during a
public health emergency and integrating
vaccine coverage as part of national
program;
• Interoperable, interconnected,
electronic real-time reporting system
with emergency operation centers, and
risk communication processes in place;
• Improve the quality and scale of
public health surveillance, national
epidemiologic data, and infectious
diseases diagnostics;
• Develop, produce, acquire, and/or
deploy novel infectious disease
surveillance assays and clinical
diagnostic tests during an outbreak;
• Strengthen laboratory biosafety and
biosecurity systems, including the
ability to scale-up in response to an
epidemic caused by a highly dangerous
pathogen;
• Real-time reporting system, and risk
communication processes in place.
Please submit an inquiry via the
ASPR Program Contact: Dr. Robin
Moudy, Robin.Moudy@hhs.gov, 202–
260–2105.
Authority: Sections 301 and 307 of the
Public Health Service Act (42 U.S.C. 241,
242l).
Dated: February 25, 2019.
Robert P. Kadlec,
Assistant Secretary for Preparedness and
Response.
[FR Doc. 2019–03846 Filed 3–1–19; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–18 –002:
Understanding Skeletal Effects of Type 1
Diabetes (R01).
Date: March 15, 2019.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–2242,
jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Urological Clinical
Small Business Applications.
Date: March 22, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK–RC2
Application Review.
Date: April 2, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\04MRN1.SGM
04MRN1
Federal Register / Vol. 84, No. 42 / Monday, March 4, 2019 / Notices
Dated: February 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–03751 Filed 3–1–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–17–031:
Characterization and Discovery of Novel
Autoantigens and Epitopes in Type 1
Diabetes (R01).
Date: March 25, 2019.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Dianne Camp, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7013, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–7682,
campd@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Mental Health Services Member Conflict.
Date: March 22, 2019.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Career Enhancement Awards.
Date: March 29, 2019.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Aileen Schulte, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6140, MSC 9608,
Bethesda, MD 20892–9608, 301–443–1225,
aschulte@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: February 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: February 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–03805 Filed 3–1–19; 8:45 am]
[FR Doc. 2019–03806 Filed 3–1–19; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:33 Mar 01, 2019
Jkt 247001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
7395
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Member Conflict
SEP.
Date: March 26, 2019.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch (SRB), DER, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, DHHS, 6710B
Rockledge Drive, Rm. 2121A, Bethesda, MD
20817, 301–451–4989, crobbins@
mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Contraception
Research Centers Program (U54 Clinical Trial
Optional).
Date: April 29–30, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase,
Pavilion 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Joanna Kubler-Kielb,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, DHHS, 6710B Rockledge
Drive, Bethesda, MD 20817, 301–435–6916,
kielbj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 84, Number 42 (Monday, March 4, 2019)]
[Notices]
[Pages 7394-7395]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03751]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA-DK-18 -002:
Understanding Skeletal Effects of Type 1 Diabetes (R01).
Date: March 15, 2019.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, jerkinsa@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Urological Clinical
Small Business Applications.
Date: March 22, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-4721, ryan.morris@nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK-RC2 Application
Review.
Date: April 2, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-4719, guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 7395]]
Dated: February 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-03751 Filed 3-1-19; 8:45 am]
BILLING CODE 4140-01-P
